Rachel Splinter
Angels for Change Launches Project GOLD Phase 2

Project GOLD is growing. Building on the success of its groundbreaking first phase, Angels for Change has launched Project GOLD Phase 2, expanding the nation's first collaborative initiative designed to protect cancer patients from drug shortages. With new manufacturer and distributor partners and an expanded portfolio of 15 high-risk oncology medicines, Phase 2 strengthens a proven model built on strategic U.S.-based buffer supply, early warning systems, and cross-sector collaboration. Following the successful protection of patient access during the national leucovorin shortage, Project GOLD continues to demonstrate that when industry leaders unite around a shared commitment to patients, together we can build a more resilient pharmaceutical supply chain and help ensure lifesaving cancer treatments remain available when patients need them most.

Angels for Change Launches Project GOLD Phase 2
A4C News, Newsletter
Rachel Splinter
Change Maker Chronicle: The March Forth Edition

The newest Change Maker Chronicle is here! Drug shortages are still impacting patients every day, but together we are pushing forward. See how we’re raising awareness, fostering advocacy, and building resilent drug supply chains to end drug shortages NOW.

Change Maker Chronicle: The March Forth Edition
Press Release
Rachel Splinter
Angels for Change Releases New White Paper ...

Angels for Change, through its Change Makers Institute, today announced the release of a new white paper, How Buffer Stock, Proactive Coordination, and Patient Advocacy Have Become a National Lifeline for Cancer Patients, highlighting the development and success of Project GOLD (Generic Oncology Lifesaving Drugs).

Angels for Change Releases New White Paper Highlighting Project GOLD as a National Model for Protecting Cancer Patients During Drug Shortages
In the News
Rachel Splinter
Laura Bray Quoted in The New York Times Article ...

Drug shortages continue to put patients at risk, threatening access to lifesaving cancer treatments and creating uncertainty for healthcare providers who are often forced to make urgent, real-time decisions about patient care.

Laura Bray Quoted in The New York Times Article on Chemotherapy Drug Shortage Concerns
Press Release
Rachel Splinter
Angels for Change and Every Cure Announce ...

Angels for Change and Every Cure announced a collaboration aimed at strengthening patient access to repurposed medicines and advancing a more resilient, patient-centered healthcare system.

Angels for Change and Every Cure share a commitment to ensuring patients have access to the treatments they need– whether that means discovering and advancing new uses for existing medicines or ensuring those medicines are available when patients need them. By combining expertise in drug shortages, supply chain resilience, and drug repurposing, the partnership will support shared efforts to expand access to lifesaving therapies. Particularly for generic essential medicines that form the backbone of healthcare. 

Angels for Change and Every Cure Announce Collaboration to Advance Patient Access to Repurposed Medicines

Angels for Change Launches Project GOLD Phase 2

Angels for Change Launches Project GOLD Phase 2

Project GOLD is growing. Building on the success of its groundbreaking first phase, Angels for Change has launched Project GOLD Phase 2, expanding the nation's first collaborative initiative designed to protect cancer patients from drug shortages. With new manufacturer and distributor partners and an expanded portfolio of 15 high-risk oncology medicines, Phase 2 strengthens a proven model built on strategic U.S.-based buffer supply, early warning systems, and cross-sector collaboration. Following the successful protection of patient access during the national leucovorin shortage, Project GOLD continues to demonstrate that when industry leaders unite around a shared commitment to patients, together we can build a more resilient pharmaceutical supply chain and help ensure lifesaving cancer treatments remain available when patients need them most.

Angels for Change Releases New White Paper Highlighting Project GOLD as a National Model for Protecting Cancer Patients During Drug Shortages

Angels for Change Releases New White Paper Highlighting Project GOLD as a National Model for Protecting Cancer Patients During Drug Shortages

Angels for Change, through its Change Makers Institute, today announced the release of a new white paper, How Buffer Stock, Proactive Coordination, and Patient Advocacy Have Become a National Lifeline for Cancer Patients, highlighting the development and success of Project GOLD (Generic Oncology Lifesaving Drugs).

Angels for Change and Every Cure Announce Collaboration to Advance Patient Access to Repurposed Medicines

Angels for Change and Every Cure Announce Collaboration to Advance Patient Access to Repurposed Medicines

Angels for Change and Every Cure announced a collaboration aimed at strengthening patient access to repurposed medicines and advancing a more resilient, patient-centered healthcare system.

Angels for Change and Every Cure share a commitment to ensuring patients have access to the treatments they need– whether that means discovering and advancing new uses for existing medicines or ensuring those medicines are available when patients need them. By combining expertise in drug shortages, supply chain resilience, and drug repurposing, the partnership will support shared efforts to expand access to lifesaving therapies. Particularly for generic essential medicines that form the backbone of healthcare. 

USP 2025 Annual Drug Shortage Report

USP 2025 Annual Drug Shortage Report

The 2025 USP Drug Shortages Report has been released, and it highlights a troubling trend: discontinuations of essential, life-saving medicines continue to rise.

In 2025, drug product discontinuations increased by 60%, reaching the highest annual total in 5 years. Drug shortages are often driven by single points of failure; medicines that are manufactured at only one facility or place in the world. When products are discontinued, the market becomes even more concentrated, leaving patients with fewer treatment options and fewer backup sources when disruptions occur.

Project PROTECT Milestone: Angels for Change and Medivant Healthcare Expand U.S. Supply of Critical Calcium Chloride Injection

Project PROTECT Milestone: Angels for Change and Medivant Healthcare Expand U.S. Supply of Critical Calcium Chloride Injection

Angels for Change announced a major milestone in Project PROTECT, its national initiative focused on building ready-to-activate domestic manufacturing capacity for essential medicines vulnerable to shortages. Through a new partnership with Medivant Healthcare, 10% Calcium Chloride Injection is now protected with onshore manufacturing readiness in the U.S., helping safeguard patient access during future supply disruptions. The collaboration strengthens domestic supply chain resilience for this critical medication used in emergency medicine, cardiac resuscitation, and intensive care.

Angels for Change Joins USP Convention

Angels for Change Joins USP Convention

At Angels for Change, we believe that ending drug shortages requires more than urgency, it requires alignment, collaboration, and bold action across every part of the healthcare ecosystem.

That’s why we’re extremely proud to be recognized by the U.S. Pharmacopeia Convention as a voting member among a diverse network of more than 450 organizations working together to strengthen trust in medicines and improve global health outcomes.

SHARE YOUR “WHY”

Every conversation, partnership, and shared story brings us closer to a future without drug shortages. At Angels for Change, we’re proud to march forth for patients everywhere.

SHARE YOUR STORY